化脓性汗腺炎的流行病学
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease defined clinically by multiple, painful inflammatory lesions occurring predominantly in flexural sites.…
要点
- HS常在青春期后不久发病,绝经是否诱导缓解尚不明确。
- 北美和欧洲患者女性与男性比例约3:1,韩国患者为1:2。
- HS与肥胖、吸烟、2型糖尿病、代谢综合征、抑郁焦虑及自杀率升高相关。
核心结论
- HS的流行病学特征在部分人群中可能无法普遍适用,患病率估计差异超过10倍是亟待解决的问题。
研究设计与样本
- 综述性研究,基于美国常规收集的医疗数据及欧洲研究等流行病学证据。
主要发现
- 北美和欧洲患者女性与男性比例约3:1,韩国患者为1:2。
- HS与肥胖、吸烟、2型糖尿病和代谢综合征等心血管疾病风险因素相关。
- 抑郁和焦虑与HS相关,HS患者完成自杀率超过对照组的2倍。
- HS与炎症性肠病、炎症性关节炎、藏毛窦、多囊卵巢综合征、唐氏综合征、阻塞性睡眠呼吸暂停和坏疽性脓皮病存在关联。
关键数值与推荐
- 欧洲研究纳入未诊断患者,患病率通常估计为1%或更高。
- 患病率估计差异超过10倍。
临床怎么用
- 临床应关注HS患者的心血管疾病风险因素、代谢合并症及心理健康问题。
- 对HS患者需评估抑郁、焦虑及自杀风险,并筛查相关慢性炎症性疾病。
局限性
- HS流行病学特征可能无法推广至所有人群。
- 美国与欧洲患病率估计差异超过10倍,争议尚未解决。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease defined clinically by multiple, painful inflammatory lesions occurring predominantly in flexural sites. Onset is typically soon after puberty; however, it remains unknown whether the menopause induces remission. In North American and European patients with HS the female-to-male ratio is approximately 3 : 1 but the ratio is 1 : 2 in South Korean patients. It may be that some elements of HS epidemiology cannot be generalized across all populations. Elements of HS epidemiology in the USA and Europe are well established, including strong associations with obesity and smoking, which may increase disease severity. There are associations between HS and other cardiovascular disease (CVD) risk factors, including type 2 diabetes and metabolic syndrome. People with HS have double the risk of death from CVD compared with those without HS and 1·5 times the risk compared with patients with psoriasis. Depression and anxiety are associated with HS and completed suicide rates in those with HS are more than double the rates in controls. Associations exist between HS and other chronic inflammatory conditions, particularly inflammatory bowel disease and inflammatory arthritis. Case-control studies demonstrate associations with pilonidal sinus, polycystic ovary syndrome, Down syndrome, obstructive sleep apnoea and pyoderma gangrenosum. Population-based studies using routinely collected healthcare data from the USA estimate a prevalence of 0·1%, suggesting HS is relatively uncommon. European studies include undiagnosed patients and typically estimate prevalence of 1% or more, suggesting a common condition. Resolving the controversy surrounding a greater than 10-fold difference in HS prevalence estimates remains a high priority.
引用
- Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020. PMID: 32880911. doi:10.1111/bjd.19435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。